1. Home
  2. CLPS vs BCTX Comparison

CLPS vs BCTX Comparison

Compare CLPS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CLPS Incorporation

CLPS

CLPS Incorporation

N/A

Current Price

$1.02

Market Cap

31.6M

Sector

Technology

ML Signal

N/A

BCTX

BriaCell Therapeutics Corp.

N/A

Current Price

$4.10

Market Cap

36.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLPS
BCTX
Founded
2005
2014
Country
Hong Kong
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
36.6M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
CLPS
BCTX
Price
$1.02
$4.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $40.00
AVG Volume (30 Days)
6.5K
★ 148.4K
Earning Date
03-06-2026
06-15-2026
Dividend Yield
★ 14.76%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$2.60
52 Week High
$1.88
$14.68

Technical Indicators

Market Signals
Indicator
CLPS
BCTX
Relative Strength Index (RSI) 57.32 64.20
Support Level $0.82 $4.10
Resistance Level $1.12 $4.51
Average True Range (ATR) 0.04 0.25
MACD -0.01 0.06
Stochastic Oscillator 71.25 85.26

Price Performance

Historical Comparison
CLPS
BCTX

About CLPS CLPS Incorporation

CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: